JP2014530855A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530855A5 JP2014530855A5 JP2014537098A JP2014537098A JP2014530855A5 JP 2014530855 A5 JP2014530855 A5 JP 2014530855A5 JP 2014537098 A JP2014537098 A JP 2014537098A JP 2014537098 A JP2014537098 A JP 2014537098A JP 2014530855 A5 JP2014530855 A5 JP 2014530855A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogel
- pharmaceutical composition
- coating
- particles
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000017 hydrogel Substances 0.000 claims description 27
- 239000008194 pharmaceutical composition Substances 0.000 claims 22
- 239000002245 particle Substances 0.000 claims 17
- 239000011248 coating agent Substances 0.000 claims 13
- 238000000576 coating method Methods 0.000 claims 13
- 239000004480 active ingredient Substances 0.000 claims 10
- 230000015556 catabolic process Effects 0.000 claims 6
- 238000006731 degradation reaction Methods 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 4
- 229920000642 polymer Polymers 0.000 claims 4
- 239000007853 buffer solution Substances 0.000 claims 3
- 239000000499 gel Substances 0.000 claims 3
- 239000007900 aqueous suspension Substances 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 239000002702 enteric coating Substances 0.000 claims 2
- 238000009505 enteric coating Methods 0.000 claims 2
- 238000001879 gelation Methods 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 229920006318 anionic polymer Polymers 0.000 claims 1
- 230000002051 biphasic effect Effects 0.000 claims 1
- 229920006317 cationic polymer Polymers 0.000 claims 1
- 230000000593 degrading effect Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161548837P | 2011-10-19 | 2011-10-19 | |
| US61/548,837 | 2011-10-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530855A JP2014530855A (ja) | 2014-11-20 |
| JP2014530855A5 true JP2014530855A5 (https=) | 2015-12-10 |
Family
ID=48135086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537098A Pending JP2014530855A (ja) | 2011-10-19 | 2012-10-05 | 二相式薬剤送達システム |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9314441B2 (https=) |
| EP (1) | EP2768488A4 (https=) |
| JP (1) | JP2014530855A (https=) |
| CN (1) | CN103957894A (https=) |
| AR (1) | AR088369A1 (https=) |
| AU (1) | AU2012326513B2 (https=) |
| BR (1) | BR112014009547A8 (https=) |
| CA (1) | CA2852447A1 (https=) |
| WO (1) | WO2013058996A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021102260A1 (en) * | 2019-11-22 | 2021-05-27 | Emanate Biomedical Inc. | Oral appliance for delivery of an antimicrobial composition |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3419657A (en) | 1964-06-23 | 1968-12-31 | Dagra Nv | Iodopanoic acid in a hydrogel |
| US4837255A (en) | 1987-03-10 | 1989-06-06 | Ciba-Geigy Corporation | Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin |
| US5030454A (en) | 1987-10-26 | 1991-07-09 | Alza Corporation | Method for delivering drug in tiny pills in liquid carrier |
| JPH04149716A (ja) * | 1990-10-15 | 1992-05-22 | Fujitsu Ltd | 情報処理装置 |
| RU2113220C1 (ru) * | 1991-07-24 | 1998-06-20 | Энзакор Пропертиз Лимитед | Композиция, способ лечения кишечной инфекции, способ неспецифической стимуляции имvунной системы, способ доставки биологически активного материала в верхние отделы тонкого кишечника |
| US5364634A (en) * | 1991-11-08 | 1994-11-15 | Southwest Research Institute | Controlled-release PH sensitive capsule and adhesive system and method |
| IL108366A (en) | 1993-03-11 | 1999-11-30 | Taro Vit Ind Ltd | Semi-solid pharmaceutical compounds and a device for their use |
| SE9301489D0 (sv) * | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
| IT1273742B (it) * | 1994-08-01 | 1997-07-09 | Lifegroup Spa | Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose |
| DE19529862A1 (de) | 1995-08-14 | 1997-02-20 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
| US6365180B1 (en) | 1998-01-20 | 2002-04-02 | Glenn A. Meyer | Oral liquid compositions |
| US6071523A (en) | 1998-06-03 | 2000-06-06 | Taro Pharmaceuticals Industries, Ltd. | Spill resistant pharmaceutical compositions in semi-solid form |
| CA2243619A1 (fr) | 1998-07-17 | 2000-01-17 | Universite De Sherbrooke | Hydrogels polyioniques a base de xanthane et chitosane pour stabilisation et relargage controle des vitamines |
| CA2345779A1 (en) * | 1999-08-27 | 2001-03-08 | Department Of National Defence | Hydrogel wound dressing containing liposome-encapsulated therapeutic agent |
| DE10224086A1 (de) | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
| CA2490142A1 (en) * | 2002-07-03 | 2004-01-15 | Abbott Laboratories | Liquid dosage forms of proton pump inhibitors |
| US7670627B2 (en) * | 2002-12-09 | 2010-03-02 | Salvona Ip Llc | pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients |
| US20040265359A1 (en) | 2003-04-17 | 2004-12-30 | Sacks Gordon S. | Oral delivery formulations of L-glutamine |
| US20080226705A1 (en) | 2004-03-31 | 2008-09-18 | Soltero Richard A | Gel delivery system for oral administration of medicaments |
| DK1758557T3 (da) * | 2004-05-11 | 2011-10-24 | Egalet Ltd | Kvældbar doseringsform omfattende gellangummi |
| WO2007001448A2 (en) * | 2004-11-04 | 2007-01-04 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
| JP4987261B2 (ja) | 2005-07-13 | 2012-07-25 | 株式会社 メドレックス | ゲル状経口製剤 |
| DOP2006000274A (es) | 2005-12-14 | 2007-10-15 | Sanofi Aventis Us Llc | Formulación de suspensión de fexofenadina |
| JP2007252341A (ja) * | 2006-03-24 | 2007-10-04 | Well Haamonii:Kk | 粉末嚥下補助食品 |
| JP2008125435A (ja) * | 2006-11-21 | 2008-06-05 | Well Haamonii:Kk | ゲル形成性組成物及びこの組成物を含有するゲル |
| US20080171110A1 (en) * | 2007-01-17 | 2008-07-17 | Geoffrey Catherwood Stuart | Solids package |
| JP2009007262A (ja) * | 2007-06-26 | 2009-01-15 | Toyo Capsule Kk | ビスホスホネート製剤 |
| JP5320091B2 (ja) * | 2009-02-02 | 2013-10-23 | 大蔵製薬株式会社 | 医薬成分が長期安定化された経口投与医薬ゼリー製剤 |
| EP2717685B1 (en) * | 2011-06-07 | 2018-08-22 | Gelesis LLC | Method for producing hydrogels |
-
2012
- 2012-10-05 AU AU2012326513A patent/AU2012326513B2/en active Active
- 2012-10-05 BR BR112014009547A patent/BR112014009547A8/pt not_active IP Right Cessation
- 2012-10-05 JP JP2014537098A patent/JP2014530855A/ja active Pending
- 2012-10-05 CA CA2852447A patent/CA2852447A1/en not_active Abandoned
- 2012-10-05 WO PCT/US2012/058829 patent/WO2013058996A1/en not_active Ceased
- 2012-10-05 CN CN201280051084.0A patent/CN103957894A/zh active Pending
- 2012-10-05 EP EP12842547.7A patent/EP2768488A4/en not_active Withdrawn
- 2012-10-09 US US13/647,816 patent/US9314441B2/en active Active
- 2012-10-18 AR ARP120103874A patent/AR088369A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zahir-Jouzdani et al. | In situ gelling and mucoadhesive polymers: why do they need each other? | |
| JP7571078B2 (ja) | 多孔性賦形剤を含む経鼻用医薬組成物 | |
| Dubashynskaya et al. | Biopolymer drug delivery systems for oromucosal application: recent trends in pharmaceutical R&D | |
| Pham et al. | Development of metronidazole-loaded in situ thermosensitive hydrogel for periodontitis treatment | |
| Lee et al. | Solid lipid nanoparticles loaded thermoresponsive pluronic–xanthan gum hydrogel as a transdermal delivery system | |
| ES2815571T3 (es) | Composiciones de silicato estabilizado y su uso como composiciones antitranspirantes | |
| Thakker et al. | Inter-polymer complex microspheres of chitosan and cellulose acetate phthalate for oral delivery of 5-fluorouracil | |
| Hong et al. | Functional nanomaterials and their potential applications in antibacterial therapy | |
| NZ601200A (en) | Pharmaceutical dosage forms comprising poly(epsilon-caprolactone) | |
| JP6207291B2 (ja) | 外用剤用組成物 | |
| Sharma et al. | Development of Abelmoschus esculentus (Okra)-based mucoadhesive gel for nasal delivery of rizatriptan benzoate | |
| JP6893075B2 (ja) | 液性免疫誘導促進用組成物及びワクチン医薬組成物 | |
| Mura et al. | Development of mucoadhesive films for buccal administration of flufenamic acid: effect of cyclodextrin complexation | |
| Qian et al. | In situ gels for nasal delivery: Formulation, characterization and applications | |
| Mali et al. | Nasal mucoadhesive in-situ gel of granisetron hydrochloride using natural polymers | |
| Laffleur | Nasal adhesive patches-approach for topical application for dry nasal syndrome | |
| El-Sayed et al. | Nanosponge hydrogel of octadecyl 3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propanoate of Alcaligenes faecalis | |
| WO2018151849A1 (en) | Particle-based multi-layer therapeutic delivery device and method | |
| Tan et al. | Fabrication and characterization of clozapine nanoemulsion sol–gel for intranasal administration | |
| Shinde et al. | In situ mucoadhesive nasal gels of metoclopramide hydrochloride: preformulation and formulation studies | |
| HK1209371A1 (en) | Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same | |
| Islam et al. | Formulation Development, Box-Behnken Design-Based Optimization and Evaluation of Cisplatin-Loaded Chitosan Nanoparticles Embedded in Mucoadhesive Buccal Film for Targeted Oral Cancer Therapy | |
| Thang et al. | Novel polymer-based hydrogels of recent research in drug delivery for disease treatment related to SARS-CoV-2 virus | |
| JP2014530855A5 (https=) | ||
| Algin-Yapar | Nasal inserts for drug delivery: an overview |